{
    "2020-08-14": [
        [
            {
                "time": "2021-08-04",
                "original_text": "The Economy May Be Struggling, but the Pet Business and the Stock Market Keep Running Strong",
                "features": {
                    "keywords": [
                        "Economy",
                        "Pet Business",
                        "Stock Market",
                        "Running Strong"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pet business",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-28",
                "original_text": "Johnson & Johnson stock outperforms market on strong trading day",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "outperforms",
                        "market",
                        "strong trading day"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-25",
                "original_text": "Merck, Big Pharmaâ€™s Quiet Giant, Looks Like a Buy",
                "features": {
                    "keywords": [
                        "Merck",
                        "Big Pharma",
                        "Quiet Giant",
                        "Buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-13",
                "original_text": "COVID-19 vaccine maker CureVac pops 200% in debut",
                "features": {
                    "keywords": [
                        "CureVac",
                        "vaccine",
                        "pops",
                        "debut"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-10",
                "original_text": "CureVac in talks with pharma companies about partnership - Sueddeutsche",
                "features": {
                    "keywords": [
                        "CureVac",
                        "partnership",
                        "pharma companies"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-05",
                "original_text": "FOCUS-Vaccine makers including Moderna must hit U.S. timing goals for full payments",
                "features": {
                    "keywords": [
                        "Vaccine makers",
                        "Moderna",
                        "timing goals",
                        "payments"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-29",
                "original_text": "Johnson & Johnson, Novavax ink vaccine deal with UK",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Novavax",
                        "vaccine deal",
                        "UK"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "Schools struggle to reopen as COVID-19 cases rise",
                "features": {
                    "keywords": [
                        "Schools",
                        "struggle",
                        "reopen",
                        "COVID-19",
                        "cases rise"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "education",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-12",
                "original_text": "Pfizer Stock Is Treading Water, but Director Ronald Blaylock Made a Big Buy",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Treading Water",
                        "Director",
                        "Ronald Blaylock",
                        "Big Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}